Collectively, these discoveries have constructed a robust framework bridging molecular insights to therapeutic innovation, positioning the PI3K/AKT/mTOR pathway as a cornerstone for targeted therapy in malignancies, including osteosarcoma (Figure 2). The gene discussed is MTOR; the disease is osteosarcoma.